Search by Drug Name or NDC
NDC 66220-0315-44 VIBATIV 15 mg/mL Details
VIBATIV 15 mg/mL
VIBATIV is a INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Cumberland Pharmaceuticals Inc.. The primary component is TELAVANCIN HYDROCHLORIDE.
MedlinePlus Drug Summary
Telavancin injection is used alone or with other medications to treat serious skin infections caused by certain types of bacteria. It is also used alone or with other medications to treat certain types of pneumonia caused by bacteria when there are no other treatment options available. Telavancin injection is in a class of medications called lipoglycopeptide antibiotics. It works by killing bacteria that cause infection. Antibiotics such as telavancin injection will not work for colds, flu, or other viral infections. Using antibiotics when they are not needed increases your risk of getting an infection later that resists antibiotic treatment.
Related Packages: 66220-0315-44Last Updated: 04/28/2024
MedLinePlus Full Drug Details: Telavancin Injection
Product Information
| NDC | 66220-0315 |
|---|---|
| Product ID | 66220-315_4d14335c-e22a-4113-a112-fcbde33b727d |
| Associated GPIs | 16280070102140 |
| GCN Sequence Number | 065734 |
| GCN Sequence Number Description | telavancin HCl VIAL 750 MG INTRAVEN |
| HIC3 | W9I |
| HIC3 Description | LIPOGLYCOPEPTIDE ANTIBIOTICS |
| GCN | 27771 |
| HICL Sequence Number | 036690 |
| HICL Sequence Number Description | TELAVANCIN HCL |
| Brand/Generic | Brand |
| Proprietary Name | VIBATIV |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | telavancin hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 15 |
| Active Ingredient Units | mg/mL |
| Substance Name | TELAVANCIN HYDROCHLORIDE |
| Labeler Name | Cumberland Pharmaceuticals Inc. |
| Pharmaceutical Class | Lipoglycopeptide Antibacterial [EPC], Lipoglycopeptides [EXT] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA022110 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 66220-0315-44 (66220031544)
| NDC Package Code | 66220-315-44 |
|---|---|
| Billing NDC | 66220031544 |
| Package | 4 VIAL, SINGLE-DOSE in 1 CARTON (66220-315-44) / 50 mL in 1 VIAL, SINGLE-DOSE |
| Marketing Start Date | 2023-12-15 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |